PIROUETTE PHARMA INC.
Pharmaceuticals · PORTSMOUTH, NH
PharmaceuticalsSEC Form D
PIROUETTE PHARMA INC. filed a Form D with the U.S. Securities and Exchange Commission on March 18, 2026, reporting $1,080,537 raised toward a $6,000,000 offering.
Incorporated in Delaware and based in PORTSMOUTH, NH, it operates in the Pharmaceuticals sector.
Companies file a Form D within 15 days of the first sale of securities in a private offering under Regulation D — an early, public signal that PIROUETTE PHARMA INC. has raised capital from private investors.
Browse more recently funded companies in Pharmaceuticals.
Executives & Directors
- CONOR CULLINANEExecutive Officer · Director · Promoter
- JOSEPH NEMMERSDirector
- PARINAZ MOTAMEDYDirector
- MATTHEW KANEExecutive Officer · Director · Promoter
- ELIJAH KAPASExecutive Officer · Promoter
Recently funded in Pharmaceuticals
Other companies that recently filed a Form D
$50.0KRaised
Matthias Therapeutics, LLC
$5.3MRaised
GridAI Technologies Corp.
$2.5MRaised
GridAI Technologies Corp.
$22.5MRaised
CNS Pharmaceuticals, Inc.
$4.9MRaised